This inventor holds 1 USPTO granted patent. Top assignee: Baylor Research Institute. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Kunitoshi Shigeyasu: Innovator in Cancer Research
Introduction
Kunitoshi Shigeyasu is a prominent inventor based in Dallas, TX (US). He has made significant contributions to the field of cancer research through his innovative work. His research focuses on methods and compositions that involve transmembrane and coiled-coil domains, particularly in relation to cancer management.
Latest Patents
Kunitoshi Shigeyasu holds a patent titled "Methods and compositions involving transmembrane and coiled-coil domains 3 (TM-CO3) in cancer." This patent outlines methods and compositions that are related to the clinical management of cancer patients based on the expression level of TMCO3. Certain embodiments of the patent provide methods for treating cancer patients who have an increased TMCO3 level compared to a normal or favorable prognosis reference level.
Career Highlights
Kunitoshi Shigeyasu is affiliated with the Baylor Research Institute, where he conducts his research. His work has been instrumental in advancing the understanding of cancer treatment and management. He has dedicated his career to improving patient outcomes through innovative research.
Collaborations
Kunitoshi collaborates with Ajay Goel, a fellow researcher in the field. Their partnership enhances the research efforts at Baylor Research Institute and contributes to the development of new cancer treatment methodologies.
Conclusion
Kunitoshi Shigeyasu is a dedicated inventor whose work in cancer research is paving the way for innovative treatment options. His patent on TMCO3 highlights the potential for improved clinical management of cancer patients.